This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $1150 | Check With Us |
500mg | $1750 | Check With Us |
1g | $2625 | Check With Us |
Cat #: V3697 CAS #: 1903008-80-9 Purity ≥ 98%
Description: Lazertinib (formerly known as GNS-1480; YH-25448; GNS1480; YH25448; LECLAZA) is an oral, highly mutant-selective and irreversible 3rd generation EGFR TKI (Tyrosine-kinase inhibitors) approved in 2021 for the treatment of lung cancer (NSCLC).
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 554.66 |
---|---|
Molecular Formula | C30H34N8O3 |
CAS No. | 1903008-80-9 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 4 mg/mL (7.2 mM)r |
Water: <1mg/mLr | |
Ethanol:<1mg/mL | |
SMILES Code | C=CC(NC1=CC(NC2=NC=CC(N3N=C(C4=CC=CC=C4)C(CN(C)C)=C3)=N2)=C(OC)C=C1N5CCOCC5)=O |
Synonyms | YH-25448; GNS 1480; YH 25448; GNS-1480; YH25448; GNS1480 |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.8029 mL | 9.0145 mL | 18.0291 mL | 36.0581 mL |
5mM | 0.3606 mL | 1.8029 mL | 3.6058 mL | 7.2116 mL |
10mM | 0.1803 mL | 0.9015 mL | 1.8029 mL | 3.6058 mL |
20mM | 0.0901 mL | 0.4507 mL | 0.9015 mL | 1.8029 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.